Nothing Special   »   [go: up one dir, main page]

MX2020007222A - Metodos para el tratamiento de afecciones inflamatorias de la piel. - Google Patents

Metodos para el tratamiento de afecciones inflamatorias de la piel.

Info

Publication number
MX2020007222A
MX2020007222A MX2020007222A MX2020007222A MX2020007222A MX 2020007222 A MX2020007222 A MX 2020007222A MX 2020007222 A MX2020007222 A MX 2020007222A MX 2020007222 A MX2020007222 A MX 2020007222A MX 2020007222 A MX2020007222 A MX 2020007222A
Authority
MX
Mexico
Prior art keywords
minocycline
inflammatory skin
skin conditions
treating inflammatory
treating
Prior art date
Application number
MX2020007222A
Other languages
English (en)
Inventor
Bijay Kumar Padhi
Rajeev Singh Raghuvanshi
Swati Kulkarni
Shavas Alikunju
Srinivas Ramchandra Sidgiddi
Anirudh Gautam
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of MX2020007222A publication Critical patent/MX2020007222A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente solicitud se refiere a un método de tratamiento de una afección inflamatoria de la piel al administrar una composición farmacéutica que comprende una dosis reducida de minociclina a un sujeto que necesite de la misma, en donde dicha administración proporciona una concentración eficaz de minociclina en plasma o fluido intersticial para tratar la afección inflamatoria de la piel.
MX2020007222A 2018-01-07 2019-01-07 Metodos para el tratamiento de afecciones inflamatorias de la piel. MX2020007222A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Publications (1)

Publication Number Publication Date
MX2020007222A true MX2020007222A (es) 2020-12-10

Family

ID=65269058

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007222A MX2020007222A (es) 2018-01-07 2019-01-07 Metodos para el tratamiento de afecciones inflamatorias de la piel.

Country Status (10)

Country Link
US (4) US11191740B2 (es)
EP (1) EP3735249A1 (es)
JP (2) JP7561029B2 (es)
KR (1) KR102705507B1 (es)
CN (1) CN111818927A (es)
BR (1) BR112020013789A2 (es)
CA (1) CA3087838A1 (es)
EA (1) EA202091653A1 (es)
MX (1) MX2020007222A (es)
WO (1) WO2019135166A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
CN112449662A (zh) 2018-07-19 2021-03-05 克拉克设备公司 用于具有升降门的驾驶室的显示器位置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440472C (en) 2001-04-05 2011-01-18 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP2368557A1 (en) 2002-04-16 2011-09-28 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080241235A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン

Also Published As

Publication number Publication date
US11191740B2 (en) 2021-12-07
US20230131030A1 (en) 2023-04-27
KR20200108018A (ko) 2020-09-16
JP7561029B2 (ja) 2024-10-03
US10905664B2 (en) 2021-02-02
US20200222345A1 (en) 2020-07-16
US20190209500A1 (en) 2019-07-11
RU2020125984A (ru) 2022-02-07
JP2024098011A (ja) 2024-07-19
US20210121420A1 (en) 2021-04-29
EP3735249A1 (en) 2020-11-11
RU2020125984A3 (es) 2022-02-07
AU2019205134B2 (en) 2024-11-07
JP2021509409A (ja) 2021-03-25
KR102705507B1 (ko) 2024-09-10
CN111818927A (zh) 2020-10-23
EA202091653A1 (ru) 2020-12-23
US11364212B2 (en) 2022-06-21
WO2019135166A1 (en) 2019-07-11
AU2019205134A2 (en) 2020-08-20
AU2019205134A1 (en) 2020-08-20
BR112020013789A2 (pt) 2021-02-17
WO2019135166A9 (en) 2020-07-16
CA3087838A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
EP4272818A3 (en) Thrombolytic agent for the treatment of thromboembolism
EP4233861A3 (en) Compositions for treatment of essential tremor
MX2018001435A (es) Metodos de tratamiento del sindrome de lennox-gastaut con fenfluramina.
MX2021004828A (es) Uso de antagonistas contra muerte programada 1 (pd-1) y ligando de muerte programada 1 (pd-l1) en combinacion con radioterapia.
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
MY188139A (en) Sodium channel modulators for the treatment of pain
MX2021000898A (es) Inhibidores de pcsk9 para usarse en el tratamiento de pacientes con hipercolesterolemia familiar heterocigota (hfhe).
MX2021000289A (es) Inhibidores pcsk9 para usarse en el tratamiento de hipercolesterolemia.
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
AR105712A1 (es) Composiciones de insulina de rápida acción
PH12016502352A1 (en) Pharmaceutical composition
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
TW201613578A (en) Pharmaceutical combinations
MX2023005014A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
MX2022014792A (es) Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican.
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
EA202193276A1 (ru) Способы лечения холангиокарциномы
MY186840A (en) Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy
MX2020007222A (es) Metodos para el tratamiento de afecciones inflamatorias de la piel.
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
MX2017013666A (es) Terapia de combinacion de agente anti-fuctactico y agente de inmunoterapia y composiciones para el tratamiento de cancer.
EA201592058A1 (ru) Применение ландиолола гидрохлорида в длительном лечении тахиаритмии
MX2022001200A (es) Metodo para el tratamiento de accidente cerebrovascular usando un derivado triciclico.
EA201990553A1 (ru) Применение придопидина для лечения ухудшения функциональной способности
UA97011U (uk) Спосіб лікування жінок з патологічним прелімінарним періодом